Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The rising prevalence of cancer and cardiovascular diseases are the main factors driving the radiopharmaceuticals market. Technological advancement, elevated healthcare expenditure, prevalence of chronic ailments, increasing geriatric population, rising awareness of radiopharmaceuticals applications in disease treatment, poor dietary habits, unhealthy lifestyle and increased awareness about the benefits of targeted alpha therapy are some of the other key factors fueling the radiopharmaceuticals market.
Major Key Players of the Radiopharmaceutical Market are:Bayer, Triad Isotopes, Lantheus, GE Healthcare, Mallinckrodt, Eli Lilly, Bracco Imaging, SIEMENS, Navidea, Nordion, IBA Group, Jubilant Pharma
Read More @ https://www.openpr.com/news/2008317/radiopharmaceutical-market-to-witness-growth-acceleration
The rising prevalence of cancer and cardiovascular diseases are the main factors driving the radiopharmaceuticals market. Technological advancement, elevated healthcare expenditure, prevalence of chronic ailments, increasing geriatric population, rising awareness of radiopharmaceuticals applications in disease treatment, poor dietary habits, unhealthy lifestyle and increased awareness about the benefits of targeted alpha therapy are some of the other key factors fueling the radiopharmaceuticals market.
Major Key Players of the Radiopharmaceutical Market are:Bayer, Triad Isotopes, Lantheus, GE Healthcare, Mallinckrodt, Eli Lilly, Bracco Imaging, SIEMENS, Navidea, Nordion, IBA Group, Jubilant Pharma
Read More @ https://www.openpr.com/news/2008317/radiopharmaceutical-market-to-witness-growth-acceleration
No comments:
Post a Comment